Wusheng Biological: On February 13, it bought in 10.8998 million yuan through financing, with a margin trading and securities lending balance of 464 million yuan.

2026-02-24 15:46:22

Abstract generation in progress

Securities Star News, on February 13th, Wusheng Biological (300357) had a margin buy-in of 10.8998 million yuan, a margin repayment of 11.9997 million yuan, a net margin sell of 1.0999 million yuan, and a margin balance of 463 million yuan. In the past 20 trading days, there have been 13 days of net margin buying.

Regarding securities lending, there were no securities lending transactions on that day.

The total margin and securities lending balance is 464 million yuan, down 0.24% from yesterday.

Quick Facts

Margin Trading and Securities Lending: Also known as “securities credit trading” or margin trading, it refers to investors providing collateral to securities firms qualified for margin trading and securities lending, borrowing funds to buy securities (margin purchase) or borrowing securities to sell (securities lending). This includes brokerages providing margin and securities lending to investors, as well as financial institutions providing financing and securities lending to brokerages.

The above content is compiled from public information by Securities Star, generated by AI algorithms (Network Information Calculation Backup 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.